Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Cantor Fitzgerald
Queensland Health
Deloitte
Cipla

Generated: May 23, 2019

DrugPatentWatch Database Preview

Drug Price Trends for GUANFACINE HCL ER

« Back to Dashboard

Drug Price Trends for GUANFACINE HCL ER

Average Pharmacy Cost for GUANFACINE HCL ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GUANFACINE HCL ER 4 MG TABLET 63304-0927-01 0.35957 EACH 2019-02-20
GUANFACINE HCL ER 1 MG TABLET 00093-5960-01 0.37012 EACH 2019-02-20
GUANFACINE HCL ER 1 MG TABLET 00378-1061-01 0.37012 EACH 2019-02-20
GUANFACINE HCL ER 1 MG TABLET 00781-5451-01 0.37012 EACH 2019-02-20
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Johnson and Johnson
Harvard Business School
Teva
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.